Export 9 results:
Author Title [ Type(Asc)] Year
Filters: Author is McCormack, Jennifer  [Clear All Filters]
Journal Article
A. F. Holtyn, Bosworth, E., Marsch, L. A., McLeman, B., Meier, A., Saunders, E. C., Ertin, E., Ullah, M. Azim, Samiei, S. Alan, Hossain, M., Kumar, S., Preston, K. L., Vahabzadeh, M., Shmueli-Blumberg, D., Collins, J., McCormack, J., and Ghitza, U. E., Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology., Contemp Clin Trials Commun, vol. 15, p. 100392, 2019.
C. I. Campbell, Saxon, A. J., Boudreau, D. M., Wartko, P. D., Bobb, J. F., Lee, A. K., Matthews, A. G., McCormack, J., Liu, D. S., Addis, M., Altschuler, A., Samet, J. H., LaBelle, C. T., Arnsten, J., Caldeiro, R. M., Borst, D. T., Stotts, A. L., Braciszewski, J. M., Szapocznik, J., Bart, G., Schwartz, R. P., McNeely, J., Liebschutz, J. M., Tsui, J. I., Merrill, J. O., Glass, J. E., Lapham, G. T., Murphy, S. M., Weinstein, Z. M., Yarborough, B. Jo H., and Bradley, K. A., PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment., Addict Sci Clin Pract, vol. 16, no. 1, p. 9, 2021.
E. Ertin, Sugavanam, N., Holtyn, A. F., Preston, K. L., Bertz, J. W., Marsch, L. A., McLeman, B., Shmueli-Blumberg, D., Collins, J., King, J. S., McCormack, J., and Ghitza, U. E., An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches, Front Psychiatry, vol. 12, p. 674691, 2021.
D. G. Birch, Bernstein, P. S., Iannacone, A., Pennesi, M. E., Lam, B. L., Heckenlively, J., Csaky, K., Hartnett, M. Elizabeth, Winthrop, K. L., Jayasundera, T., Hughbanks-Wheaton, D. K., Warner, J., Yang, P., Fish, G. Edd, Teske, M. P., Sklaver, N. L., Erker, L., Chegarnov, E., Smith, T., Wahle, A., VanVeldhuisen, P. C., McCormack, J., Lindblad, R., Bramer, S., Rose, S., Zilliox, P., Francis, P. J., and Weleber, R. G., Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial., JAMA Ophthalmol, vol. 136, no. 8, pp. 849-856, 2018.
D. M. Boudreau, Lapham, G., Johnson, E. A., Bobb, J. F., Matthews, A. G., McCormack, J., Liu, D., Campbell, C. I., Rossom, R. C., Binswanger, I. A., Yarborough, B. Jo, Arnsten, J. H., Cunningham, C. O., Glass, J. E., Murphy, M. T., Zare, M., Hechter, R. C., Ahmedani, B., Braciszewski, J. M., Horigian, V. E., Szapocznik, J., Samet, J. H., Saxon, A. J., Schwartz, R. P., and Bradley, K. A., Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems., J Subst Abuse Treat, vol. 112S, pp. 41-48, 2020.
L. J. Mooney, Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindblad, R., and Ling, W., Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology., Contemp Clin Trials, vol. 34, no. 2, pp. 196-204, 2013.
D. S. Carrell, Cronkite, D. J., Shea, M., Oliver, M., Luce, C., Matson, T. E., Bobb, J. F., Hsu, C., Binswanger, I. A., Browne, K. C., Saxon, A. J., McCormack, J., Jelstrom, E., Ghitza, U. E., Campbell, C. I., Bradley, K. A., and Lapham, G. T., Clinical Documentation of Patient-Reported Medical Cannabis Use in Primary Care: Toward Scalable Extraction Using Natural Language Processing Methods, Subst Abus, vol. 43, no. 1, pp. 917-924, 2022.
W. Ling, Hillhouse, M. P., Saxon, A. J., Mooney, L. J., Thomas, C. M., Ang, A., Matthews, A. G., Hasson, A., Annon, J., Sparenborg, S., Liu, D. S., McCormack, J., Church, S., Swafford, W., Drexler, K., Schuman, C., Ross, S., Wiest, K., P Korthuis, T., Lawson, W., Brigham, G. S., Knox, P. C., Dawes, M., and Rotrosen, J., Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study., Addiction, vol. 111, no. 8, pp. 1416-27, 2016.
J. F. Bobb, Qiu, H., Matthews, A. G., McCormack, J., and Bradley, K. A., Addressing identification bias in the design and analysis of cluster-randomized pragmatic trials: a case study., Trials, vol. 21, no. 1, p. 289, 2020.